FAS and Circle of Kindness have achieved a price reduction for the first gene therapy Elevidys

Retrieved on: 2025-04-07 15:38:11

Tags for this article:

Muscular dystrophy

Biotechnology

Rare diseases

Genetic engineering

Duchenne muscular dystrophy

Sarepta Therapeutics

Gene therapy

Delandistrogene moxeparvovec

Dystrophin

Steve Wilton

Becker muscular dystrophy

Russia

Click the tags to see associated articles and topics

FAS and Circle of Kindness have achieved a price reduction for the first gene therapy Elevidys. View article details on hiswai:

Excerpt

It is the world's first single-dose agent for gene replacement therapy in Duchenne muscular dystrophy (DMD) patients. The drug is not registered in ...

Article found on: gxpnews.net

View Original Article